Literature DB >> 1437550

Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).

D P Siderovski1, T Matsuyama, E Frigerio, S Chui, X Min, H Erfle, M Sumner-Smith, R W Barnett, T W Mak.   

Abstract

A new method is described for the direct construction of randomly mutagenized genes by applying the polymerase chain reaction (PCR) to an oligonucleotide synthesized using doped nucleotide reservoirs. We have demonstrated the utility of this method by generating a library of mutant HIV-1 tat genes. Several arbitrarily selected, inactive tat clones were sequenced to evaluate the extent of the mutagenesis. Moreover, fourteen recombinants encoding varying levels of transcriptional trans-activator activity were isolated by transient transfection of sub-library pools into a HeLa cell line bearing an HIV-LTR-chloramphenicol acetyltransferase (CAT) reporter gene. Sequence data revealed a spectrum of alterations including nucleotide substitutions, insertions, and deletions, suggesting that mutations arose from both the doped DNA synthesis and the subsequent PCR 'rescue' of full-length product. Sequence comparison between inactive and active Tat clones revealed a selection pressure against amino-acid substitutions within the N-terminal domains of Tat, indicating the importance of this region to trans-activation competence. In addition, single and double missense mutations within the basic-rich, TAR RNA-binding domain were seen to be tolerated within active Tat clones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437550      PMCID: PMC334336          DOI: 10.1093/nar/20.20.5311

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?

Authors:  L S Tiley; P H Brown; B R Cullen
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

2.  Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.

Authors:  A P Rice; F Carlotti
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Mapping of HIV-1 Tat protein sequences required for binding to Tar RNA.

Authors:  J Kamine; P Loewenstein; M Green
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

4.  Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.

Authors:  C Southgate; M L Zapp; M R Green
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

5.  Saturation mutagenesis using mixed oligonucleotides and M13 templates containing uracil.

Authors:  B H Horwitz; D DiMaio
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

6.  The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.

Authors:  J Rappaport; S J Lee; K Khalili; F Wong-Staal
Journal:  New Biol       Date:  1989-10

7.  Rapid generation of DNA fragments by PCR amplification of crude, synthetic oligonucleotides.

Authors:  R W Barnett; H Erfle
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

8.  The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.

Authors:  U Delling; S Roy; M Sumner-Smith; R Barnett; L Reid; C A Rosen; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 9.  Regulation of HIV gene expression by RNA-protein interactions.

Authors:  C A Rosen
Journal:  Trends Genet       Date:  1991-01       Impact factor: 11.639

10.  Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.

Authors:  M Sumner-Smith; S Roy; R Barnett; L S Reid; R Kuperman; U Delling; N Sonenberg
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more
  4 in total

1.  Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.

Authors:  S Mitola; R Soldi; I Zanon; L Barra; M I Gutierrez; B Berkhout; M Giacca; F Bussolino
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus.

Authors:  K Verhoef; B Berkhout
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Exploring the functional robustness of an enzyme by in vitro evolution.

Authors:  M A Martinez; V Pezo; P Marlière; S Wain-Hobson
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

4.  Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors.

Authors:  B Maschera; E Furfine; E D Blair
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.